GlassScriptPhysician profile
Rita V Linkner
NPI 1295057578
$27,240.52
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $26K · 2021: $265.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $26,211.69 | 2019-2021 | |
| Janssen Biotech, INC. | $235.59 | 2019-2021 | |
| Lilly USA, LLC | $123.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $119.74 | 2019 | |
| Mayne Pharma Commercial LLC | $108.01 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $74.14 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $68.14 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $64.54 | 2019 | |
| Merz North America, INC. | $49.35 | 2019 | |
| Sun Pharmaceutical Industries INC. | $45.48 | 2019-2020 | |
| Genzyme Corporation | $39.32 | 2020-2021 | |
| Celgene Corporation | $23.83 | 2019 | |
| Abbvie INC. | $21.31 | 2020 | |
| Dermira, INC. | $21.18 | 2019 | |
| Allergan, INC. | $20.05 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $14.30 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Linkner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.